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Abstract 
Loricrin is a major component of the epidermal cornified cell envelope, and is expressed only in 
terminally differentiated keratinocytes. This cell differentiation-specific expression pattern 
suggests specific suppression of loricrin gene expression in undifferentiated keratinocytes as well 
as its activation in differentiated keratinocytes. We identified a negative regulatory sequence 
element in the first intron of the mouse loricrin gene involved in suppression of loricrin gene 
expression in undifferentiated keratinocytes. A database search indicated that this sequence 
contained the putative inverted YY1 binding motif. Constructs with point mutations in the putative 
YY1 binding motif showed increased reporter activity, indicating that YY1 negatively regulates 
loricrin gene transcription. Co-transfection experiments using a YY1 expression vector revealed 
that YY1 represses loricrin promoter activity. Western blotting and immunohistochemical analyses 
indicated that YY1 is more abundant in undifferentiated than in differentiated keratinocytes. These 
findings suggest that YY1 contributes to specific loricrin gene expression in differentiated 
keratinocytes by suppression of its transcription in undifferentiated keratinocytes. Furthermore, we 
demonstrated that forced expression of YY1 in differentiated keratinocytes results in specific 
down-regulation of expression of other early and late differentiation markers. 
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Introduction 
The mammalian epidermis is a constantly renewing stratified squamous epithelium. Epidermal 
keratinocytes are the major cell type in the epidermis and are responsible for generating the 
protective barrier as a consequence of a tightly regulated, highly compartmentalized differentiation 
process that culminates in a mature stratified epidermis (Roop, 1995). Differentiation proceeds 
from the basal layer, through the spinous layer, granular layer, and ultimately the stratum corneum 
where fully differentiated keratinocytes are sloughed off into the environment as flattened squames. 
As keratinocytes differentiate into granular-layer cells, they show induction of late-differentiation 
products, such as filaggrin (Fisher et al, 1987; Rothnagel et al, 1987), involcrin (Rice and Green, 
1979), and loricrin (Mehrel et al, 1990). This latter molecule, loricrin, is a major component of the 
cornified cell envelope, a specialized structure that replaces the plasma membrane and contributes 
to the protective barrier function of the stratum corneum (Koch et al, 2000). Loricrin is expressed 
in a keratinocyte- and differentiation-specific manner (Steven and Steinert, 1994), and in situ 
hybridization analyses have shown that loricrin transcripts are localized only in the upper spinous 
and granular layers of the epidermis (Mehrel et al, 1990; Hohl et al, 1991b). Loricrin gene 
expression is strictly regulated mainly at the level of transcription. Expression of loricrin has been 
shown to be induced on induction of differentiation of cultured keratinocytes by increasing the 
calcium concentration in the culture media (Hohl et al, 1991a). Elevation of calcium concentration 
in the culture medium triggers differentiation, as reflected by the expression of differentiation 
markers, such as keratins 1 and 10, loricrin, and involucrin. The calcium switch model thus allows 
simulation of in vivo differentiation. Using this inducible culture system, the tissue- and 
differentiation-specific expression of loricrin provides an ideal experimental model in which to 
study the transcription factors involved in the control of keratinocyte- and differentiation-specific 
gene expression. It has been reported that 6.5 kb of upstream sequence is required for 
epidermis-specific expression of the mouse loricrin gene, and an evolutionarily highly conserved 
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AP-1 element in the loricrin proximal promoter is essential but not sufficient for loricrin expression 
(DiSepio et al, 1995). Further experiments demonstrated that the Sp-1 binding site located 
immediately upstream of the AP1 site in the loricrin proximal promoter is also essential for loricrin 
expression, and molecular interactions of SP-1/Sp-3 and AP1 proteins suggest a simple model for 
regulation of the loricrin proximal promoter (Kawachi et al. unpublished data). However, the 
precise mechanism of regulation of specific loricrin gene expression is still unclear. Little is known 
about the molecular mechanism involved in suppression of loricrin expression in basal epidermal 
keratinocytes. 
In the present study, we found that YY-1, a constitutive nuclear member of the GLI-Krüppel 
family of zinc finger transcription factors, is expressed dominantly in undifferentiated 
keratinocytes, and contributes to specific suppression of loricrin gene expression in 
undifferentiated keratinocytes. Furthermore, we report here that YY1 also suppresses the 
expression of other differentiation marker proteins, such as keratin 1, keratin 10, and involucrin in 
differentiated keratinocytes.  
 
Materials and Methods 
Plasmids  The isolation and characterization of a 14-kb genomic loricrin gene fragment has been 
reported elsewhere (DiSepio et al, 1999). A 2.6-kb loricrin genomic fragment containing 1.5 kb of 
upstream regulatory sequence, the TATA box, 47 bp of the untranslated exon 1, and 1.1 kb of intron 
1 was inserted into the plasmid pGL3-basic (Promega, Madison, WI) in-frame with the 
promoter-less luciferase reporter cassette (firefly luciferase) to generate 1.5-1.1LOR. To obtain a 
series of intron 1 deletion constructs, 1.5-1.1 LOR was subjected to EcoRV/NsiI digestion, which 
eliminated a 371-bp fragment yielding the construct DEL1, and PstI/EcoRV digestion, which 
eliminated a 374-bp fragment yielding the construct DEL2 (Fig. 1). To generate constructs DEL3, 
DEL4, and DEL5, the specific fragments between the PstI and EcoRV sites in intron 1 were 
amplified by PCR using 5’ primers corresponding to positions 200, 250, or 300 bp upstream from 
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the EcoRV site each of which contained an artificial PstI site. PCR was performed using the 
common 3’ primer that included the EcoRV site. The PCR product was ligated with the DEL2 
construct digested with PstI and EcoRV (Fig.1). For point mutagenesis of the YY1 recognition site, 
the 5’ primer with an artificial PstI site and a point mutation on the YY-1 recognition sequence (Fig. 
1 MUT) was generated. PCR and ligation reactions were performed using 5’ PstI I and 3’ EcoRV 
sites as described above. The mammalian expression vector pCMV-YY1 was kindly provided by 
Dr. Yang Shi (Harvard Medical School, Boston, MA). All deletions and mutations were confirmed 
by DNA sequencing. 
Cell culture and transient cell transfection  Primary mouse keratinocyte cultures were prepared 
as described previously (Rothnagel et al, 1993). Primary keratinocytes were isolated and then 
grown in low-calcium medium (0.05 mM calcium, 50% fibroblast-conditioned medium (Harper et 
al, 1988; Rothnagel et al, 1993), 8% FCS in EMEM (BioWhittaker, Walkersville, MD)) for 48 
hours prior to transfection. Then, keratinocytes were cultured in either high-calcium medium (0.12 
mM calcium, 50% fibroblast-conditioned medium, 8% FCS in EMEM) or in low-calcium medium. 
In induction of terminal differentiation, keratinocytes were still more cultured in very high-calcium 
medium (0.35 mM calcium, 50% fibroblast-conditioned medium) for 24 hours after culture in 
high-calcium medium. Low-calcium medium was supplemented with 4.0 ng/ml of EGF (Becton 
Dickinson, Bedford, MA) unless otherwise indicated. Mouse dermal fibroblasts were cultured in 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal calf serum (FCS). 
Cells were transfected using the LT1 reagent in accordance with the manufacturer’s 
recommendations (Panvera, Madison, WI). To examine expression in undifferentiated 
keratinocytes, cells were cultured in low-calcium medium for 48 hours after transfection and then 
harvested. Expression in differentiated keratinocytes was assessed by growing transfected cells for 
24 hours in low-calcium medium without EGF, followed by two days in high-calcium medium. To 
determine transfection efficiencies and to normalize expression levels, all cultures were 
co-transfected with plasmid pRL-TK (Promega). This plasmid contains the Renilla luciferase gene 
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under the control of the HSV TK promoter. Luciferase assays were performed using a 
dual-luciferase assay kit according to the manufacturer’s protocol (Promega). Firefly and sea pansy 
luciferase activities were measured with a Monolight 2020 luminometer (Analytical Luminescence 
Laboratory, Ann Arbor, MI). Each construct was tested in triplicate.  
Electrophoretic Mobility Shift Assays (EMSA) Whole-cell extracts were obtained from 
dissociated epidermal keratinocytes. Cells were washed with PBS, resuspended in storage buffer 
(20 mM HEPES, pH 7.8, 400 mM KCl, 20% glycerol, 2 mM DTT), and then frozen in a dry 
ice/ethanol bath. Supernatants were thawed on ice, centrifuged at 15,000×g, and aliquoted. Nuclear 
extracts were prepared from differentiated or undifferentiated keratinocytes as described 
previously (Schreiber et al, 1989). Protein concentrations were determined with a Bradford assay 
kit (BioRad, Hercules, CA), and equal amounts of protein were used for each DNA/protein binding 
reaction. Oligonucleotides were end-labeled using 32P-ATP and T4 polynucleotide kinase 
(Invitrogen, Carlsbad, CA) according to the manufacturer’s instructions. Labeled probes (2 ng; 
105-106 cpm) were incubated with 1-3 μg of cell extract for 15 to 30 minutes on ice. In some 
experiments, 1 μg/reaction of anti-YY1 antibody (sc-1703X; Santa Cruz Biotechnology, Santa 
Cruz, CA) was added. The DNA/protein complexes were analyzed by native polyacrylamide gel 
electrophoresis (PAGE) and visualized by autoradiography of the dried gels. The sequence of 
radiolabeled oligonucleotide for YY1 binding corresponded to the region of +400 to +425 on the 
first intron of the loricrin gene. The sequence of the mutant YY1 binding oligonucleotide is shown 
in Fig. 1C as MUT. Oligonucleotides with the consensus binding sequence for cold competition 
experiments and anti-actin antibody (sc-7210) as a control antibody for supershift assay were 
purchased from Santa Cruz Biotechnology (sc-2533).  
Immunohistofluorescence staining Immunohistofluorescence staining was performed using an 
antibody to YY1 (sc-1703, Santa Cruz Biotechnology). Skin specimens obtained from neonatal 
mice were embedded in Tissue-TekII OCT compound (Sakura Finetek, Torrance, CA) and frozen. 
Sections 5 μm thick were cut on a cryostat, and placed on uncoated slides. For staining, slides were 
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incubated with primary antibody for 30 min, followed by washing with PBS. Slides were incubated 
with fluorescein isothiocyanate-conjugated secondary antibody (sc-2012; Santa Cruz 
Biotechnology), mounted, and then analyzed by fluorescence microscopy (Nikon, Tokyo, Japan).  
Immunoblotting analysis Whole-cell extracts were prepared from differentiated or 
undifferentiated keratinocytes. Nuclear extracts were prepared from differentiated or 
undifferentiated keratinocytes as described previously (Schreiber et al, 1989). For Western blotting 
analysis of the expression of pCMV-YY1, whole-cell extracts from the transfected keratinocytes 
were obtained 48 hours after transfection. Proteins were separated by 8.5%-10% SDS-PAGE and 
then transferred onto nitrocellulose membranes (Schleicher & Schuell, Dassel, Germany). Blots 
were probed successively with antibodies to YY1 (sc-281; Santa Cruz Biotechnology), keratin 14 
(PRB-155P; Covance, Richmond, CA), keratin 5 (PRB-160P; Covance), involucrin (PRB-142C; 
Covance), and loricrin (PRB-145P; Covance). After detection of primary antibody binding, blots 
were stripped using ImmunoPure IgG elution buffer (Pierce Chemical Company, Rockford, IL). 
Primary antibody binding was detected using PicoWest SuperSignal ECL Substrate (Pierce) and 
exposure to Biomax MR film (Kodak, Rochester, NY).  
 
Results 
Identification of the negative regulatory element in the first intron of the loricrin gene The 
expression of loricrin is strictly linked to keratinocyte differentiation, suggesting its specific 
repression in undifferentiated keratinocytes as well as activation in differentiated keratinocytes. To 
locate the negative regulatory sequences involved in suppression of loricrin gene expression in 
undifferentiated keratinocytes, a series of 5’ deletions were made and placed upstream of the 
luciferase reporter gene. The constructs were analyzed by transient transfection into primary 
murine dermal fibroblasts or primary murine keratinocytes cultured under either 
non-differentiation (0.05 mM Ca2+) or differentiation-inducing (0.12 mM Ca2+) culture conditions. 
The loricrin gene consists of two exons, the 5’ non-coding first exon and the second 3’ exon 
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containing the entire coding sequence, separated by one intron. On transfection into differentiated 
keratinocytes, the construct containing the promoter region, the untranslated first exon, and the first 
intron (-1.5+1.1LUC) showed a decrease in reporter activity of over 50% as compared to those 
containing only the promoter region (-0.3LUC, -0.5LUC and -1.5LUC) (Fig. 1A). This result 
suggested that the first intron contains a negative-acting cis-element. 
Further deletion analysis indicated that the region from +398 to +428 is responsible for the 
suppressive activity of the first intron (Fig. 1B, DEL1-5). A transcription factor database search 
identified a putative inverted binding motif for YY1 in this sequence (Fig. 1B, DEL5). The 
point-mutated constructs with contiguous 2-bp substitutions at the putative YY1-binding motif 
showed increases of about 50% in reporter activity (Fig. 1C, MUT/DEL5), indicating that YY1 
negatively regulates loricrin gene transcription in keratinocytes.  
YY-1 physically binds to the functional negative element in the first intron of loricrin gene 
Electrophoretic mobility shift assays were performed to determine whether YY1 actually binds to 
the functional negative element. A fragment of 25 bp derived from the negative element in the first 
intron was used as a probe. One distinct DNA/protein complex was detected using nuclear extracts 
prepared from epidermal keratinocytes (Fig. 2, lane 1). Preincubation with 100-fold molar excess 
of an unlabeled wild-type oligonucleotide inhibited complex formation (Fig. 2, lane 3). 
Preincubation with even a 100-fold molar excess of unlabeled mutant oligonucleotide with 2-bp 
contiguous substitutions within the negative element failed to inhibit complex formation (Fig. 2. 
lanes 4 and 5). Unlabeled oligonucleotides containing a typical YY1 consensus binding site 
completely inhibited complex formation (Fig. 2, lanes 6 and 7). To confirm more directly that YY1 
protein binds to the negative element, we added a polyclonal antibody against YY1 to the protein 
extracts in these electrophoretic mobility shift assays. As shown in Fig. 2, lanes 8 and 9, anti-YY1 
antibody inhibited protein/DNA complex formation and generated supershifted bands. These 
experiments clearly demonstrated that YY1 can bind to the functional negative element in the first 
intron of the loricrin gene. Another shifted band (indicated by asterisks in Fig. 2) was observed that 
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was competed with the wild-type but not the mutant oligonucleotide. Interestingly, the typical YY1 
consensus oligonucleotide did not compete with this band. These findings suggest that a 
DNA-binding factor other than YY1 also binds to the sequence of the negative regulatory element.  
YY1 expression is down-regulated during keratinocyte differentiation Immunohistochemical 
staining of the epidermis was performed to investigate epidermal YY1 expression in vivo. YY1 
was strongly expressed mainly in the cytoplasm in cells of the basal epidermal layer, while its 
expression was weak in the suprabasal layers (Fig. 3A). To examine the changes in level of YY1 
protein in keratinocytes during differentiation, Western blotting analysis was performed using 
nuclear extracts prepared from undifferentiated and differentiated keratinocytes. As shown in 
Fig. 3B, YY1 was more abundant in the nuclear extracts of cells grown under non-differentiation 
(0.05 mM Ca2+) than differentiation-inducing conditions (0.12 mM Ca2+). To confirm 
down-regulation of the DNA-binding activity of YY1 by keratinocyte differentiation, the nuclear 
extracts of cells grown under non-differentiation and differentiation-inducing conditions were 
analyzed by electrophoretic mobility shift assay. As shown in Fig. 3C, the intensity of the shifted 
band was much higher in the lanes containing nuclear extracts from cells grown under 
non-differentiation (0.05 mM Ca2+) than differentiation-inducing conditions (0.12 mM Ca2+). 
These observations indicated that the DNA-binding activity of YY1 was elevated in 
undifferentiated keratinocytes and down-regulated in differentiated keratinocytes. This 
differentiation-dependent down-regulation of YY1 expression suggested that YY1 contributes to 
the specific expression of loricrin gene in differentiated keratinocytes by suppression of its 
transcription in undifferentiated cells. 
Overexpressed YY-1 functionally suppresses loricrin promoter activity To determine the 
specific functional effect of YY1 on loricrin gene transcriptional activity in keratinocytes, transient 
co-transfection experiments were performed in cultured keratinocytes. The loricrin reporter 
construct p0.5-1.1 Luc containing 0.5 kb of 5’-flanking region and 1.1 kb of the first intron, was 
transfected into keratinocytes grown under non-differentiation or differentiation-inducing 
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conditions in the presence of the YY1 expression vector pCMV-YY1 or control empty vector. As 
shown in Fig. 4, YY-1 decreased loricrin reporter activity to less than 3% of the control level in 
both undifferentiated and differentiated keratinocytes. Thus, YY1 was shown to act as a potent 
negative regulator of loricrin gene expression.  
YY1 decreases expression of keratinocyte differentiation marker genes Next, we analyzed the 
effects of YY1 on expression of endogenous differentiation marker genes in keratinocytes grown in 
low- or high-calcium medium. Western blotting analysis was used to monitor expression of the 
basal markers keratin 5 and 14, the early differentiation markers keratin 1 and 10, and the terminal 
differentiation markers involucrin and loricrin. Differentiating keratinocytes in the presence of a 
high level of calcium (0.12 mM) and terminally differentiated keratinocytes in the presence of a 
very high calcium level (0.35 mM) showed marked decreases in the expression of the early and 
terminal differentiation markers after transfection with YY1 expression vector,, respectively. 
Interestingly, there were no differences in the expression of the basal keratinocyte markers keratin 
5 or 14 by transfection of YY1. Therefore, forced expression of YY1 in differentiated keratinocytes 
resulted in down-regulation of early and terminal differentiation markers, indicating that the early 
and late differentiation markers are specifically suppressed in differentiated keratinocytes in a 
YY1-dependent manner. 
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Discussion 
A number of regulatory elements and transcription factors have been shown to be involved 
specifically in the regulation of cell type-specific or differentiation-specific epidermal gene 
expression. Several ubiquitous transcription factors, such as AP-1, AP-2, Sp1/3, and NFκB, have 
been shown to be involved in the regulation of the epidermal gene expression (Eckert et al, 1997a; 
Eckert et al, 1997b). It is interesting that ubiquitously expressed transcription factors appear to 
control the specific expression of epidermal genes. The AP-1 site 6.5 kb upstream of the cap site is 
essential for epidermis-specific mouse loricrin gene expression (DiSepio et al, 1995). A recent 
study indicated that synergistic interactions among multiple transcription factors are important for 
keratinocyte-specific expression of the human loricrin gene (Jang and Steinert, 2002). However, 
the mechanisms and factors involved in the specific suppression of loricrin gene expression in 
basal undifferentiated keratinocytes remain to be elucidated.  
To identify the negative elements involved in regulation of loricrin expression in 
undifferentiated keratinocytes, we investigated the functional role of the first intron. Our results 
identified an YY1-binding motif in the first intron as a negative regulatory element. In this study, 
we showed that YY1 is expressed at high levels in the epidermal basal layer and that it suppresses 
transcription of the loricrin gene in basal undifferentiated keratinocytes. 
YY1 is a member of the GLI-Krüppel family of transcription factors and several lines of 
evidence suggest that YY1 is a multifunctional transcriptional regulator, involved in initiation, 
activation, or repression of transcription depending on both the promoter and cellular context. YY1 
mRNA and protein have been identified in a number of different tissues and cell types, suggesting 
that it is expressed both constitutively and ubiquitously (Shi et al, 1997). However, YY1 
expression level increases rapidly in quiescent NIH3T3 cells in response to serum and insulin-like 
growth factor-1 (Flanagan, 1995). YY1 DNA-binding activity has also been shown to be regulated 
during differentiation. For example, YY1 DNA binding activity decreases during differentiation of 
human teratocarcinoma cells (Liu et al, 1994) and in myoblast differentiation (Lee, T.C. et al, 
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1992), but increases during aging (Adrian et al, 1996). In addition, to differentiation-specific gene 
regulation, a recent study also indicated that YY1 contributes to the T cell-specific expression 
pattern of CD3delta (Ji et al, 2002). The results of the present study indicated that YY1 protein is 
expressed at high levels in undifferentiated basal keratinocytes and is down-regulated during 
differentiation both in vivo and in vitro. The level of YY1 DNA-binding activity also decreased 
markedly during differentiation, suggesting that YY1 may regulate undifferentiated 
keratinocyte-specific gene expression. As YY1 protein is degraded by the calcium-activated 
protease calpain II and the 26 S proteosome during myoblast differentiation (Walowitz et al, 1998), 
the calcium-dependent, post-translational proteolytic mechanism might be important for the 
specific inactivation of YY1 during keratinocyte differentiation. In the present study, we showed 
that YY1 bound to the negative regulatory element in intron 1 of the loricrin gene and functionally 
repressed loricrin gene transcriptional activity. Taken together, our findings indicate that YY1 
contributes to the specific suppression of loricrin gene expression in undifferentiated keratinocytes. 
Furthermore, we demonstrated that the overexpression of YY1 in keratinocytes cultured under 
differentiation-inducing conditions resulted in marked decreases in the expression of not only 
loricrin but also of the other early and late differentiation marker genes, keratin 1, keratin 10, and 
involucrin, while the levels of expression of the undifferentiated marker genes keratin 5 and keratin 
14 were relatively unaffected. These findings suggest that YY1 plays an important role in 
maintenance of the undifferentiated phenotype in keratinocytes. A functional YY1-binding site 
was identified 1.9 kb upstream of the human keratin 1 gene (Lee et al., unpublished data) and our 
database search indicated that human and mouse keratin 10 genes have a possible YY1-binding site 
in their promoter regions. However, the promoter regions of keratin 5 and 14 genes contain no 
putative YY1-binding sites. YY1 has been implicated in the repression of genes that are intimately 
involved in various differentiation processes (Shrivastava and Calame, 1994). Repression of gene 
expression by YY1 may ensure correct temporal and spatial expression of differentiation-specific 
molecules (Raich et al, 1995). The relief of YY1 repression of the skeletal α-actin promoter is 
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thought to be important in myoblast differentiation (Lee, T.C. et al, 1992). The globin gene switch 
process during hematopoiesis has been suggested to involve YY1 (Orkin, 1995). The ability of 
ubiquitous YY1 to suppress differentiation-specific gene expression may be due to its ability to 
antagonize differentiation-specific transcriptional activators. In addition, activation of cell 
cycle-related genes, such as c-Myc, by YY1 may contribute to the repression of 
differentiation-specific gene expression (Riggs et al, 1993). 
YY1 has been shown to regulate the gene transcription through physical and functional interactions 
with various transcription factors and co-factors. The specific actions of the ubiquitously expressed 
factor YY1 can be largely explained by its interactions with a diverse array of other 
sequence-specific factors and co-factors (Shi et al, 1997). A number of epidermal key regulatory 
proteins, such as Sp1, C/EBPβ, and CBP/p300, have been shown to interact with YY1 (Lee, J.S. et 
al, 1993; Bauknecht et al, 1996; Thomas and Seto, 1999), suggesting that these interactions are 
important in determining the particular function of YY1 at a given promoter. Regulation of human 
loricrin gene expression has been shown to require interactions among a number of ubiquitous 
transcription factors, the fine balance of the availability of these proteins, and recruitment of the 
co-activator p300/CBP (Jang and Steinert, 2002). Previously, we reported that both AP-1 and 
Sp1/Sp3 elements located 14-40 bp upstream from the TATA box are crucial for 
differentiation-specific murine loricrin gene expression and that they interact both functionally and 
physically with each other (unpublished data). Our findings suggested that AP-1 and Sp1/Sp3 
proteins form a core transcription complex that can strongly activate transcription from the loricrin 
gene promoter in differentiated keratinocytes. Thus, the repression of loricrin transcription by YY1 
in undifferentiated keratinocytes may be due to the coordinated interaction between YY1 and the 
core transcription complex composed of AP-1 and Sp1. 
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Figure legends 
Figure 1 
Identification of negative elements in the first intron of the loricrin gene (A) Transient 
expression of the luciferase reporter gene under the control of the mouse loricrin 5’-upstream 
sequence. Plasmids containing serial deletions of the loricrin gene 5’-flanking region (-1.5Luc, 
-0.5Luc, and -0.3Luc) or containing 0.5 kb of 5’-flanking sequence and 1.1 kb of the first intron 
(-0.5+1.1Luc) linked to reporter vectors carrying the firefly luciferase gene (Luc) were transiently 
transfected into differentiated keratinocytes cultured in high-calcium medium (0.12 mM Ca2+; 
black bars), undifferentiated keratinocytes cultured in low-calcium medium (0.05 mM Ca2+; open 
bars), or normal dermal fibroblasts (dotted bars). The vector nomenclature is based on the length of 
the 5’ loricrin sequence in each construct (e.g., –1.5Luc contained sequences from positions +1 bp 
to –1.5 kb). Cells were harvested and assayed for luciferase activity as described in Materials and 
Methods. Error bars represent one standard deviation of triplicate transfections. Differences in 
transfection efficiency were normalized relative to sea pansy luciferase activity produced by the 
co-transfected pRL-tk vector. The relative luciferase activities shown are the ratios of firefly 
luciferase activities derived from pGL3-loricrin promoter constructs to sea pansy luciferase 
activities from the pRL-tk vector. (B) Identification of an element that is critical for the negative 
activity of the first intron. Plasmids containing various deletions in the first intron of the loricrin 
gene (DEL1-5) or the wild-type first intron (WT) ligated into reporter cassettes carrying the firefly 
luciferase gene (Luc) were transiently transfected into differentiated keratinocytes. The arrow at 
DEL5 indicates the critical region (398-428) for the negative activity of the first intron. Relative 
luciferase activity was as defined in Fig. 1A. (C) Effects of the YY1-binding motif on negative 
transcriptional activity of the first intron. Differentiating keratinocytes were transfected with DEL5 
or mutated reporter plasmid with contiguous 2-bp point mutation in the YY1-motif (MUT/DEL5). 
Mutated sequences in YY1-binding motifs (TG to CA) are shown in closed boxes.  
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Figure 2 
YY1 binds specifically to the putative negative motifs in intron 1 of the loricrin gene 
Electrophoretic mobility shift assays were performed using radiolabeled wild-type 
oligonucleotide containing the putative YY1-binding motif and nuclear extracts from epidermal 
keratinocytes. Incubations were carried out in the presence or absence of a 10-fold or a 100-fold 
excess of unlabeled wild-type oligonucleotide (lanes 2 and 3), mutant oligonucleotide (lanes 4 
and 5), or typical YY1-binding consensus oligonucleotide (lanes 6 and 7). Nuclear extracts were 
preincubated with 1 μg (lane 8) or 2 μg (lane 9) of anti-YY1 antibody followed by incubation with 
radiolabeled wild-type probe. The arrowhead indicates a potential supershifted band. 
Preincubation with anti-actin antibody was also performed to confirm the specificity of the 
anti-YY antibody (right panel). The protein-DNA complexes were separated by PAGE. The 
specific band corresponding to YY1-DNA complex is indicated by an arrow. The faster moving 
band, which showed partial competition with the wild-type and YY1 consensus oligonucleotides 
but not the mutant oligonucleotide, is indicated by an asterisk. 
 
Figure 3 
Expression profile of YY1 protein in epidermis and cultured keratinocytes. (A) Expression of 
YY1 in stratified epithelium in vivo. Frozen sections of murine neonatal back skin were 
immunostained with an antibody to YY1. The dotted line represents the basement membrane zone. 
CL, cornified layer; SL, squamous layer; BL, basal layer; DE, dermis. (B) Changes in expression 
of YY1 through differentiation of cultured keratinocytes. Nuclear extracts from cultured 
undifferentiated (0.05 mM Ca2+) and differentiated (0.12 mM Ca2+) keratinocytes were examined 
for YY1 protein expression by Western blotting analysis. Equivalent quantities of extract were 
subjected to PAGE and transferred onto nitrocellulose membranes. The membranes were incubated 
with anti-YY1 antibody (upper panel). As an internal reference for relative amounts of protein, the 
blots were re-probed using anti-lamin A/C antibody (lower panel). (C) Changes in DNA-binding 
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activity of YY1 through differentiation of cultured keratinocytes. Electrophoretic mobility shift 
assays were performed using nuclear extracts from cultured undifferentiated (0.05 mM Ca2+, lanes 
1 and 2) and differentiated (0.12 mM Ca2+, lanes 3 and 4) keratinocytes. Nuclear extracts from 
cultured undifferentiated (lanes 5 and 6) and differentiated (lanes 7 and 8) keratinocytes were 
preincubated with 1 μg of anti-YY1 antibody followed by incubation with radiolabeled wild-type 
probe. 
 
Figure 4 
YY1 suppresses loricrin promoter activity in transiently transfected keratinocytes. The 
loricrin reporter construct p0.5-1.1 Luc, which contains 0.5 kb of 5’-flanking region and 1.1 kb of 
intron 1, was transfected into non-differentiating or differentiating keratinocytes in the presence of 
YY1 expression vector, pCMV-YY1, or control empty vector. Open bars indicate the luciferase 
activity of the corresponding constructs in undifferentiated keratinocytes grown in low calcium 
medium (0.05 mM Ca2+). Black bars indicate luciferase activity in differentiated keratinocytes 
grown in high-calcium medium (0.12 mM Ca2+).  
 
Figure 5 
Effects of YY1 overexpression on the expression of keratinocyte differentiation markers. 
Total cell extracts from undifferentiated keratinocytes or differentiated keratinocytes transfected 
with YY1 expression vector or vehicle vector were analyzed by immunoblotting with specific 
antibodies for the indicated proteins: A, basal keratinocyte markers, keratins 5 and 14; B, early 
differentiation markers, keratins 1 and 10; C, terminal differentiation markers, involucrin and 
loricrin. Undifferentiated keratinocytes were grown in low-calcium medium (0.05 mM Ca2+), and 
differentiated keratinocytes were grown in high- or very high-calcium media  (0.12 mM/0.35 mM 
Ca2+, respectively). NT, non-transfected keratinocytes; YY1, transfected with YY1 expression 
vector pCMV-YY1; Vehicle, transfected with empty vehicle vector, pCMV. 
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